PTH: Potential role in management of heart failure

D. Gruson, A. Buglioni, John C Jr. Burnett

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Biomarkers play an important role for the diagnosis and prognosis of heart failure (HF), a disease with high morbidity and mortality as well as a huge impact on healthcare budgets. Parathyroid hormone (PTH) is a major systemic calcium-regulating hormone and an important regulator of bone and mineral homeostasis. PTH testing is important for differential diagnosis of calcemia related disorders and for the management of patients with chronic kidney disease. As secondary hyperparathyroidism has been evidenced in HF patients, PTH testing might be relevant in HF patients for risk stratification and more personalized selection of treatment.

Original languageEnglish (US)
Pages (from-to)290-296
Number of pages7
JournalClinica Chimica Acta
Volume433
DOIs
StatePublished - Jun 10 2014

Fingerprint

Parathyroid Hormone
Heart Failure
Secondary Hyperparathyroidism
Hypercalcemia
Testing
Biomarkers
Budgets
Chronic Renal Insufficiency
Minerals
Bone
Differential Diagnosis
Homeostasis
Hormones
Calcium
Morbidity
Delivery of Health Care
Bone and Bones
Mortality
Therapeutics

Keywords

  • Aldosterone
  • BNP
  • FGF-23
  • Heart failure
  • Multimarker
  • Parathyroid hormone

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical
  • Medicine(all)

Cite this

PTH : Potential role in management of heart failure. / Gruson, D.; Buglioni, A.; Burnett, John C Jr.

In: Clinica Chimica Acta, Vol. 433, 10.06.2014, p. 290-296.

Research output: Contribution to journalArticle

Gruson, D. ; Buglioni, A. ; Burnett, John C Jr. / PTH : Potential role in management of heart failure. In: Clinica Chimica Acta. 2014 ; Vol. 433. pp. 290-296.
@article{82e8a8bcba544167a781d79e5369351b,
title = "PTH: Potential role in management of heart failure",
abstract = "Biomarkers play an important role for the diagnosis and prognosis of heart failure (HF), a disease with high morbidity and mortality as well as a huge impact on healthcare budgets. Parathyroid hormone (PTH) is a major systemic calcium-regulating hormone and an important regulator of bone and mineral homeostasis. PTH testing is important for differential diagnosis of calcemia related disorders and for the management of patients with chronic kidney disease. As secondary hyperparathyroidism has been evidenced in HF patients, PTH testing might be relevant in HF patients for risk stratification and more personalized selection of treatment.",
keywords = "Aldosterone, BNP, FGF-23, Heart failure, Multimarker, Parathyroid hormone",
author = "D. Gruson and A. Buglioni and Burnett, {John C Jr.}",
year = "2014",
month = "6",
day = "10",
doi = "10.1016/j.cca.2014.03.029",
language = "English (US)",
volume = "433",
pages = "290--296",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",

}

TY - JOUR

T1 - PTH

T2 - Potential role in management of heart failure

AU - Gruson, D.

AU - Buglioni, A.

AU - Burnett, John C Jr.

PY - 2014/6/10

Y1 - 2014/6/10

N2 - Biomarkers play an important role for the diagnosis and prognosis of heart failure (HF), a disease with high morbidity and mortality as well as a huge impact on healthcare budgets. Parathyroid hormone (PTH) is a major systemic calcium-regulating hormone and an important regulator of bone and mineral homeostasis. PTH testing is important for differential diagnosis of calcemia related disorders and for the management of patients with chronic kidney disease. As secondary hyperparathyroidism has been evidenced in HF patients, PTH testing might be relevant in HF patients for risk stratification and more personalized selection of treatment.

AB - Biomarkers play an important role for the diagnosis and prognosis of heart failure (HF), a disease with high morbidity and mortality as well as a huge impact on healthcare budgets. Parathyroid hormone (PTH) is a major systemic calcium-regulating hormone and an important regulator of bone and mineral homeostasis. PTH testing is important for differential diagnosis of calcemia related disorders and for the management of patients with chronic kidney disease. As secondary hyperparathyroidism has been evidenced in HF patients, PTH testing might be relevant in HF patients for risk stratification and more personalized selection of treatment.

KW - Aldosterone

KW - BNP

KW - FGF-23

KW - Heart failure

KW - Multimarker

KW - Parathyroid hormone

UR - http://www.scopus.com/inward/record.url?scp=84899496964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899496964&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2014.03.029

DO - 10.1016/j.cca.2014.03.029

M3 - Article

C2 - 24704306

AN - SCOPUS:84899496964

VL - 433

SP - 290

EP - 296

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

ER -